About Marilyn Thompson
Form D filings for IMMvention Therapeutix in 2023 list Marilyn Thompson as executive officer.
Marilyn Thompson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Marilyn Thompson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Marilyn Thompson works with at each company, as listed on that company's latest Form D.
IMMvention Therapeutix, Inc. · Form D, Jan 10, 2023
JT
Jenny Ting
Director
MV
Mark Velleca
Director
AG
Anil Goyal
Chief Executive Officer and director
LO
Lev Osherovich
Director
BS
Benjamin Scruggs
Director
MC
Matthew Cohen
Director